Single agent talacotuzumab demonstrates limited efficacy but considerable toxicity in elderly high-risk MDS or AML patients failing hypomethylating agents
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
[2020]
|
| In: |
Leukemia
Year: 2019, Volume: 34, Issue: 4, Pages: 1182-1186 |
| ISSN: | 1476-5551 |
| DOI: | 10.1038/s41375-019-0645-z |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/s41375-019-0645-z Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/s41375-019-0645-z |
| Author Notes: | Anne Sophie Kubasch, Freya Schulze, Aristoteles Giagounidis, Katharina S. Götze, Jan Krönke, Katja Sockel, Jan Moritz Middeke, Fatiha Chermat, Silke Gloaguen, Martin Puttrich, Carmen Weigt, Doreen William, Pierre Fenaux, Richard F. Schlenk, Christian Thiede, Sebastian Stasik, Anna Mies, Lionel Adès, Uta Oelschlägel, Uwe Platzbecker |
| Item Description: | Published online: 3 December 2019 Gesehen am 23.04.2020 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1476-5551 |
| DOI: | 10.1038/s41375-019-0645-z |